In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right-sided CRC + no advanced adenoma in the index colonoscopy + no adenoma in the 1 yr control could skip the 3rd yr control colonoscopy. https://t.co/Dir6YK3i7A https://t.co/Db1OMwau27
How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: a predictive model.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2020 – May 2020Where it's discussed
-
X / Twitter11 posts
-
Facebook2 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions express moderate support for the study's insights, with mentions of rethinking colonoscopy timing to improve patient outcomes, such as the suggestion to skip 3-year procedures in certain cases. The tone indicates a focus on practical application and healthcare efficiency, using phrases like 'rethinking surveillance' and 'consider not performing,' reflecting a balanced interest in the potential impact on clinical practices.
Most posts show agreement with the idea of rethinking colonoscopy schedules based on the predictive model, suggesting support for its potential to improve patient care.
The discussions indicate moderate interest, focusing on practical implications and healthcare efficiency rather than deep scientific debate.
Users demonstrate active engagement by referencing the study's practical suggestions and expressing considerations about changing current protocols.
Posts imply that the publication could influence clinical practices, potentially reducing unnecessary procedures and optimizing surveillance.
Top posts
Most liked on X and BlueskyConsider not performing colonoscopy at 3 years in selected cases. https://t.co/bLwokKeixr https://t.co/P9QHhfcmb7
“How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: a predictive model” by Leonardo Frazzoni, Liboria Laterza, Alessandro Mussetto et al. Read more here: https://t.co/8xlI6bP7yO https://t.co/UtWNldUr4M
RT @MarcoBus1967: In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right…
RT @MarcoBus1967: In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right…
RT @MarcoBus1967: In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right…
All mentions
Identifying Low-Risk Patients for Metachronous Neoplasms Post-Colon Cancer Treatment
This video discusses methods to determine which colon cancer patients are less likely to develop metachronous neoplasms, highlighting a predictive model based on recent research to improve post-treatment surveillance…
RT @MarcoBus1967: In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right…
RT @MarcoBus1967: In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right…
RT @MarcoBus1967: In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right…
RT @MarcoBus1967: In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right…
RT @MarcoBus1967: In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right…
RT @MarcoBus1967: In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right…
RT @MarcoBus1967: In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right…
RT @MarcoBus1967: In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right…
In the post-COVID19 era, maximazing apropriateness of colonoscopy is a must. Rethinking surveillance: patients with right-sided CRC + no advanced adenoma in the index colonoscopy + no adenoma in the 1 yr control could skip the 3rd yr control colonoscopy. https://t.co/Dir6YK3i7A https://t.co/Db1OMwau27
“How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: a predictive model” by Leonardo Frazzoni, Liboria Laterza, Alessandro Mussetto et al. Read more here: https://t.co/8xlI6bP7yO https://t.co/UtWNldUr4M
Consider not performing colonoscopy at 3 years in selected cases. https://t.co/bLwokKeixr https://t.co/P9QHhfcmb7
MB
A
EJ
JA
FM
CS
MJ
RN
P
IC
丰丰